Dashboard
1
With a growth in Net Sales of 9.77%, the company declared Outstanding results in Sep 25
- The company has declared positive results for the last 3 consecutive quarters
- ROCE(HY) Highest at 7.17%
- INTEREST COVERAGE RATIO(Q) Highest at 978.58
- DIVIDEND PAYOUT RATIO(Y) Highest at 41.54%
2
With ROE of 4.29%, it has a fair valuation with a 1.22 Price to Book Value
3
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.35%
0%
20.35%
6 Months
80.33%
0%
80.33%
1 Year
128.33%
0%
128.33%
2 Years
105.58%
0%
105.58%
3 Years
98.06%
0%
98.06%
4 Years
120.48%
0%
120.48%
5 Years
90.02%
0%
90.02%
Tianshui Zhongxing Bio-Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.99%
EBIT Growth (5y)
3.46%
EBIT to Interest (avg)
1.94
Debt to EBITDA (avg)
2.02
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
0.33
Tax Ratio
0
Dividend Payout Ratio
91.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.85%
ROE (avg)
4.17%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
1.22
EV to EBIT
36.65
EV to EBITDA
12.94
EV to Capital Employed
1.17
EV to Sales
2.62
PEG Ratio
0.02
Dividend Yield
2.96%
ROCE (Latest)
3.19%
ROE (Latest)
4.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
623.00
567.50
9.78%
Operating Profit (PBDIT) excl Other Income
237.50
242.70
-2.14%
Interest
15.80
14.10
12.06%
Exceptional Items
4.70
1.30
261.54%
Consolidate Net Profit
130.80
135.70
-3.61%
Operating Profit Margin (Excl OI)
212.60%
242.70%
-3.01%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 9.78% vs 30.40% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -3.61% vs 571.78% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,098.30
1,934.70
8.46%
Operating Profit (PBDIT) excl Other Income
583.70
414.00
40.99%
Interest
57.00
77.10
-26.07%
Exceptional Items
6.80
15.30
-55.56%
Consolidate Net Profit
334.60
126.60
164.30%
Operating Profit Margin (Excl OI)
156.50%
65.80%
9.07%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 8.46% vs 0.20% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 164.30% vs -20.68% in Dec 2024
About Tianshui Zhongxing Bio-Technology Co., Ltd. 
Tianshui Zhongxing Bio-Technology Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






